index - Équipe Biomarqueurs Radiopharmaceutiques et Neurochimiques

Documents en texte intégral

82

Notices

87

 

Mots clés

18FFDG A-BETA Amyotrophic lateral sclerosis Amyloid‐β Rat Adverse events 18F-florbetapir PET Choroid plexus Alzheimer’s disease Recent memory Dementia 5-HT6 receptor 5-HT1A receptors Amyloid Magnetic resonance elastography Serotonin Maladie d'Alzheimer Démence à corps de Lewy Anti-CD20 Multiple system atrophy Neuroinflammation 14-3-3 protein FMRI Psychiatry Locus coeruleus PET/MRI Analytical Chemistry Creutzfeldt-Jakob disease Radiopharmaceutical 5-HT1A 5-Ht1A and 5-HT6 receptors Biomarqueurs Acute ischemic stroke 11CPF-3274167 Biomarker 18FFDG micro PET Asparaginyl‐tRNA synthetase Brain Parkinson's disease 5-HT 1A receptors Agonistes Synucleinopathies 18 FF13640 System-level consolidation 3D virtual histopathology Pharmaco-fUS Amyloid-beta peptides Striatum Drug discovery Non-human primate Amyloid-β plaques Anxiety behavior 11Cyohimbine Atomoxetine Alzheimer's disease Central nervous system 5-HT 6 receptor Alert system Proteinopathies Biomarkers Alphasynucléine Multiple sclerosis Acute inflammatory demyelinating polyneuropathy Animal model Cerebrospinal fluid Middle cerebral artery occlusion 18 F2FNQ1P Amyloid-beta Neuropharmacology Radiotracer Α2-adrenergic receptors TEP Maladies neurodégénératives Atmospheric pollution Acute respiratory distress syndrome Alpha-synuclein Frontotemporal lobar degeneration Positron emission tomography Agonist AMAN syndrome Stroke Neurodegenerative diseases Diagnosis Alzheimer diagnosis Agonists Inflammation Animal models Magnetic resonance imaging Noradrenaline 18FFluorodeoxyglucose Alzheimer Remote memory Analytical confounders LCS Neuroimaging 11CR-PK11195 Accident vasculaire cérébral PET imaging